The DOI matches its Crossref record.
Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy
Abstract
Reduced nerve perfusion is an important factor in the etiology of diabetic neuropathy. Studies in streptozotocin-induced diabetic rats show that nerve conduction velocity (NCV) and blood flow deficits are corrected by treatment with vasodilator drugs, with angiotensin II and endothelin-1 antagonists being particularly important. The AT1 antagonist ZD7155 also prevents diabetic deficits in regeneration following nerve damage, indicating that hypoperfusion is an important limitation for nerve repair. Metabolic changes include high polyol pathway flux, increased advanced glycosylation, elevated oxidative stress, and impaired ω-6 essential fatty acid metabolism. Aldose reductase inhibitors (ARIs) restore NCV via their effects on perfusion. ARI action probably depends on blocking the conversion of glucose to sorbitol, thus preventing depletion of vasa nervorum glutathione, an important endogenous free radical scavenger. Free radicals cause vascular endothelium damage and reduced nitric oxide vasodilation. Inhibition of advanced glycosylation and autoxidation (autoxidative glycosylation), major sources of free radicals, by aminoguanidine or transition metal chelators, corrects neurovascular dysfunction. Evening primrose oil supplies γ-linolenic acid (GLA) to improve vasodilator eicosanoid synthesis in diabetes, correcting nerve blood flow and NCV deficits. Interactions between some of these mechanisms have therapeutic implications. Thus, combined ARI and evening primrose oil treatment produced a 10-fold amplification of NCV and blood flow responses. Similarly, GLA effects are markedly enhanced when given in combination with ascorbate as ascorbyl-GLA. Thus, metabolic abnormalities combine to produce deleterious changes in nerve perfusion that make a major contribution to the etiology of diabetic neuropathy. The potential importance of multi-action therapy is stressed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because metal chelators and hydroxyl radical scavengers have also been demonstrated to be effective in preventing diabetes-induced vascular and neural dysfunction, it is likely that the formation of hydroxyl radicals also contributes to impairment of vascular reactivity and nerve function in diabetes (46–51, 145).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [47]
Citations
Cited by
Sorted by citations
Items 201–300 of 313
Oxidative Stress in the Metabolic Syndrome
Calhau, C., & Santos, A. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9701-0_3 · Cited by 9
Épidémiologie et physiopathologie des complications dégénératives du diabète sucré
Raccah, D. (2004) · EMC - Endocrinologie · doi:10.1016/j.emcend.2003.10.003 · Cited by 21
Catanzaro, O. L., Capponi, J. A., Martino, I. D., et al. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.10.003 · Cited by 9
Diabetic neuropathy: pathogenetic background, current and future therapies
Sima, A. A. F. (2001) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.1.2.225 · Cited by 9
Pai, S. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00011-x · Cited by 8
Goh, J. K., & Koh, L. (2023) · Diabetology International · doi:10.1007/s13340-023-00629-x · Cited by 7
Schwann cells in diabetic neuropathy
Mizisin, A. P. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31050-1 · Cited by 7
Chang, J., Wu, C., Hsieh, C., Li, Y., Wang, T., & Liou, J.-C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00099 · Cited by 7
“Elevated oxidative stress and free radicals cause vascular endothelium damages and reduce nitric oxide bioavailability (26, 27).”
BackgroundRelationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy
Hwang, J.-W., Pyun, S., & Kwon, H.-K. (2016) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2016.40.1.56 · Cited by 8
Aldose reductase inhibitors for the treatment of diabetic polyneuropathy
Chalk, C., Benstead, T., & Moore, F. G. A. (2004) · doi:10.1002/14651858.cd004572 · Cited by 7
Lee, C.-W., Jin, J.-S., Kwon, S., Jin, C., Cho, S., Park, S.-U., Jung, W., Moon, S., Park, J., Ko, C., et al. (2022) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2022.101657 · Cited by 7
Cooper, M. A., Jack, M. M., Ryals, J. M., Hayley, P., Escher, T. E., Koch, L. G., Britton, S. L., Raupp, S. M., Winter, M. K., McCarson, K. E., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.780 · Cited by 6
Advocacy for Carbomedtherapy (Carbon Dioxide Therapy) in the Treatment of Diabetic Neuropathy
Boudjenah, N. (2020) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.169 · Cited by 6
“It is caused by the aggression of hyperglycemia [1-4].”
BackgroundTesfaye, S. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-075-1_6 · Cited by 6
Thrainsdottir, S. (2009) · Lund University Publications (Lund University) · Cited by 6
Redhwan, M. A. M., Hariprasad, M. G., Samaddar, S., Bafail, D. A., Hard, S. A. A. A., Guha, S., & Dhavale, A. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2431316 · Cited by 7
“…the extent of neurovascular damage resulting from diabetes, likely due to decreased NBF causing hypoxia and contributing to slower nerve conduction [55,56]. this finding aligns with existing literature that underscores a causal link between peripheral nerve perfusion deficits and conduction…”
Жарких, Е. В., Loktionova, Y. I., Kozlov, I., et al. (2020) · doi:10.1117/12.2552464 · Cited by 5
“Studies show that the development of DPN is associated not only with metabolic, but also with vascular disorders, and in particular with a decrease in nerve blood flow.(7,8) Although there have been numerous studies of changes in symptoms of DPN in the treatment of ALA, studies of the effect of this substance on the s…”
BackgroundGilloteaux, J., Subramanian, K., Solomon, N., & Nicaise, C. (2018) · Ultrastructural Pathology · doi:10.1080/01913123.2018.1522405 · Cited by 5
Chronic oral Silybum Marianum aqueous extract attenuates streptozotocin-diabetic neuropathy
Baluchnejadmojarad, T., & Roghani, M. (2009) · Journal of Diabetes & Metabolic Disorders · Cited by 4
Effects of Bogijetong-Tang on Diabetic-peripheral Neuropathy Induced by Streptozotocin in the Mouse
Bin, L. J., Jung, K. C., Sik, C. C., et al. (2013) · 대한한의학회지 · doi:10.13048/jkm.13018 · Cited by 4
Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
Colberg, S. R. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s12136 · Cited by 4
“In addition, no subjects were using insulin, angiotensin II receptor blockers, or angiotensin-converting inhibitors, due to their potential enhancing effects on nerve blood flow.(9) Their sedentary status pretraining was verified using a modified version of the Harvard Alumni Physical Activity Questionnaire.”
Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
Colberg, S. R. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s12136 · Cited by 4
Role of Electro-Diagnostic Tests In Early Detection of Diabetic Neuropathy
Ali, Z., Hakim, M., Islam, M., et al. (1970) · Bangladesh Journal of Neuroscience · doi:10.3329/bjn.v24i1.3038 · Cited by 4
El-Bahr, S. M. (2014) · British Biotechnology Journal · doi:10.9734/bbj/2014/11121 · Cited by 4
Tratamiento de la neuropatía autonómica diabética
Millán, C. O. (2005) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(05)71266-4 · Cited by 4
Çakır, N., Yetkin, İ., Karakoç, A., et al. (2000) · Current Therapeutic Research · doi:10.1016/s0011-393x(00)90014-6 · Cited by 4
Ticse, R., Chavez, J. V., & Pimentel, R. (2012) · Revista Médica Herediana · doi:10.20453/rmh.v18i3.920 · Cited by 4
Nwankwo, M. J., Okoye, G. C., Egwuonwu, A. V., et al. (2017) · Cited by 4
sayed, L. A. E., Elattar, S., & el Tablawy, N. M. (2012) · Cited by 4
Calcium signaling in diabetic neuropathy
Voitenko, N. V. (2004) · Neurophysiology · doi:10.1007/s11062-005-0022-6 · Cited by 4
“various metabolic [1], vascular [2, 3], and other [4, 5] abnormalities were demonstrated as pathogenetic”
Background[Contribution of electroneuromyography to the evaluation of neuropathy in diabetic patients].
Escobar-Rodríguez, D. Á., Rivera-Ibarra, D. B., Juárez-López, M. D. J., et al. (2006) · PubMed · Cited by 4
Ricardi, F., Reccalenda, I., Boscia, G., et al. (2024) · European Journal of Ophthalmology · doi:10.1177/11206721241248682 · Cited by 3
Pai, S. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00013-x · Cited by 3
Efficacy of ozone therapy on visual evoked potentials in diabetic patients
Izadi, M., Javanbakht, M., Sarafzadeh, A., Einollahi, B., Futuhi, F., Vahedi, Z., Zhao, S., Jafari, N. J., Hosseini, M. S., Nejad, J. H., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01114-w · Cited by 3
Hamed, S. A., El-kossi, A. E. A., Abdellah, M. M., et al. (2011) · Journal of Clinical and Experimental Investigations · doi:10.5799/ahinjs.01.2011.03.0049 · Cited by 3
Nerve electrophysiological changes in rats with early induced diabetes
Tarhzaoui, K., Behar, A., Lestrade, R., et al. (2008) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.95.2008.2.4 · Cited by 3
Fatty Acid Metabolism in Diabetes
Bhathena, S. J. (2007) · Food science and technology · doi:10.1201/9781420006902.ch47 · Cited by 2
Edmundsson, D., Toolanen, G., & Stål, P. (2017) · Muscle & Nerve · doi:10.1002/mus.25715 · Cited by 3
The diabetic foot syndrome, diagnosis and consequences
Meijer, J. W. G. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 3
Diabetic Cardiovascular Autonomic NeuropathyPreprint
Siddig, A., Ahmed, A. H. M., Ahmed, K. A. H. M., & Omer, M. E. A. (2021) · Research Square · doi:10.21203/rs.3.rs-646618/v1 · Cited by 3
Hariprasad, M. G. (2019) · Archives of Diabetes & Obesity · doi:10.32474/ado.2019.02.000135 · Cited by 2
Strokov, I. A., & Фокина, А. С. (2016) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2016-17-28-33 · Cited by 2
Strokov, I. A., & Фокина, А. С. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20171173150-55 · Cited by 2
“Связь метаболических и сосудистых факторов неоднократно рассматривалась в литературе [8, 9].”
Diabetes Mellitus and Dyspepsia
Duvnjak, L. S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1730-0_18 · Cited by 2
Cellular mechanisms underlying the development of diabetic neuropathies
Kostyuk, E. P. (1998) · Neurophysiology · doi:10.1007/bf02463061 · Cited by 2
Eldeen, A., El-kossi, A., Abdellah, M. M., et al. (2011) · Cited by 2
The Efficacy Of Hyperbaric Oxygen Theraphy For The Treatment Of Diabetic Autonomic Neuropathy
(2002) · The Internet Journal of Neurology · doi:10.5580/d36 · Cited by 2
Cardiac Autonomic Neuropathy: Is it a Cardiovascular Risk Factor in Type 2 Diabetes
Kempler, P. (2003) · Springer eBooks · doi:10.1007/978-3-642-59352-9_16 · Cited by 2
Microvascular complications in type 2 diabetes
King, G. L., & Okeke, E. (2009) · Dialnet (Universidad de la Rioja) · doi:10.1016/b978-84-8086-683-5.50010-x · Cited by 2
Treatment of Painful Diabetic Neuropathy
Kelkar, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2417-2_12 · Cited by 1
Effects of Diabetes and Insulin Resistance on Endothelial Functions
Fu, J., Yu, M. G., Li, Q., Park, K., & King, G. L. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_3 · Cited by 1
Lischke, B., Mohammad, J., Rheimann, R., et al. (2025) · Cancer & Metabolism · doi:10.1186/s40170-025-00409-y · Cited by 1
“Similarly, it may be worth investigating whether PSC could delay diabetic neuropathy, an equally complex pathology involving reduced mitochondrial bio-energetics and microvascular disease [19–21] to ameliorate this chronic debilitating condition.”
Winata, J., Panda, A. L., & Azis, R. A. (2015) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-015-0085-4 · Cited by 1
Осипенко, А. Н., Orlov, D. A., & Акулич, Н. В. (2012) · Neurophysiology · doi:10.1007/s11062-012-9323-8 · Cited by 1
“Analysis of the FA composition in the erythrocyte mass showed that complicated DM-1 is characterized by a greater content of saturated palmitic (C16:0) FA (26.90 ± 0.50% vs. 25.91 ± 0.61%, P 0.05) and smaller amounts of saturated stearic (C18:0) acid (23.61 ± 0.49% vs. 25.26 ± 0.32%, P 0.001).”
InfluentialOXIDATIVE STRESS CONTRIBUTIONS TO CHRONIC COMPLICATIONS IN DIABETES
Savu, O., Ionescu-Tirgoviste, C., & Paulescu, N. (2008) · Cited by 1
Diabetes and Health Care: An Overview
Abhilash, M., & Augustine, R. (2014) · Apple Academic Press eBooks · doi:10.1201/b16415-6 · Cited by 2
EFFECT OF THERAPEUTIC LASER IN THE MANAGEMENT OF DIABETIC NEUROPATHY PAIN
Jannu, C., Devi., V., Suganthirababu, P., et al. (2019) · Ethiopian Journal of Health Development · Cited by 1
Total Fenolic Contents of Ferula elaeochytris Root Extract and Its Effect on Glucose Levels
Eser, N., KARTLAŞMIŞ, K., Uçar, Y., et al. (2020) · Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi · doi:10.31020/mutftd.648699 · Cited by 1
“It has been reported in some experimental diabetic animal models that various antioxidants prevent the development of diabetic impotence.(3,7,8)”
BackgroundEffect of Different Level of Zeolite and Perlite on The Physiological Performance of Awassi Lambs
Tarsh, A. F., & Al-Yasseri, A. J. (2021) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/923/1/012039 · Cited by 1
Épidémiologie et physiopathologie des complications dégénératives du diabète sucré
Raccah, D. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(04)74279-1 · Cited by 1
Metabolic Mechanisms in Diabetic Neuropathy
Yorek, M. A. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_15 · Cited by 1
Diabetes and Complications at a Glance for Pharmacy Researchers
Mangesh, K., Vidyasagar, G., & Ashwini, K. (2014) · Cited by 1
Kotlęga, D., Gołąb-Janowska, M., Zaborowski, G., Ciećwież, S. M., & Nowacki, P. (2016) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2016.07.003 · Cited by 1
Calcium Signaling in Diabetic Neuropathy
Voitenko, N. V. (2004) · Neurophysiology · doi:10.1007/s11062-004-0010-2 · Cited by 1
“various metabolic [1], vascular [2, 3], and other [4, 5] abnormalities were demonstrated as pathogenetic”
BackgroundEndothelzellaktivierung bei Diabetes mellitus
Andrassy, M., Schiekofer, S., Chen, J., Humpert, P. M., Bai, L., Chen, B., Schleicher, E., Nawroth, P. P., & Bierhaus, A. (2001) · Hämostaseologie · doi:10.1055/s-0037-1619518 · Cited by 1
“) die Aktivierung des Polyolstoffwechsels (22, 28, 30, 33, 39, 62, 75, 110), 2.”
BackgroundInfluential(2013) · Elsevier eBooks · doi:10.1016/b978-0-443-06992-5.00010-4 · Cited by 2
The Role of Protein Kinase C Activation in the Development of Diabetic Vascular Complications
King, G. L. (1998) · Endocrine updates · doi:10.1007/978-1-4615-5569-8_10 · Cited by 1
Soluble Cellular Adhesion Molecules in Patients With Diabetes Mellitus
Eschen, O., Christensen, J. H., & Schmidt, E. B. (2006) · The Endocrinologist · doi:10.1097/01.ten.0000249139.45366.36
Transgenic and Gene Knockout Analysis of Diabetic Neuropathy
Chung, S. K., & Chung, S. S. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-311-0_4
The Mechanisms Underlying the Effects of C-Peptide on Type 1 Diabetic Neuropathy
Kamiya, H., Zhang, W., & Sima, A. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-391-2_8
McCarthy, A. D. (2001) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2578
Henshaw, F. R. (2014) · The Sydney eScholarship Repository (The University of Sydney)
Romagnoli, M. (2007) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Arnol, V. (2012) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2765
THE BIOCHEMICAL BASIS OF DIABETIC COMPLICATIONS - A ROLE OF OXIDATIVE STRESS?
Aaseth, J., & Bøe, O. W. (1999) · Elsevier eBooks · doi:10.1533/9781845698409.2.74
Alexandrova, A., Georgieva, A. P., Petrov, L., et al. (2006) · Open Life Sciences · doi:10.2478/s11535-006-0013-7
Oenothera biennis (Oenotheraceae ou Onagraceae) : onagre
Ghédira, K., Goetz, P. W., & Lejeune, R. (2011) · Phytothérapie · doi:10.1007/s10298-011-0648-z
Hariprasad, M. G., Razdan, R., & Yasha, T. C. (2015) · International Journal of Bioassays · doi:10.21746/ijbio.2015.09.0014
DISRUPTION OF RAGE SIGNALING PREVENTS SYMPATHETIC NEURON MALFUNCTION IN HIGH GLUCOSE CONDITIONS
Chandna, A. R. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
Zangiabadi, N., Ahrari, M. N., & Nakhaee, N. (2008) · The Professional Medical Journal · doi:10.29309/tpmj/2008.15.01.2638
Carvalho, C. (2013) · Estudo Geral (Universidade de Coimbra)
Capote, A. E. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
ORIGINALNI NAUČNI RADOVI ORIGINAL STUDIES
Ilin, M., Slankamenac, P., & Jovin, Z. (2011)
Fatty Acid Metabolism in Skeletal Muscle and Nerve, and in Neuromuscular Disorders
Yao, J., & Rebouche, C. J. (2007) · Food science and technology · doi:10.1201/9781420006902.ch48
Problemas neuropáticos de los miembros inferiores en los pacientes diabéticos
Tanenberg, R. J., & Donofrio, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-84-8086-367-4.50003-5
Glukosetoleranz und Diabetes mellitus im Alter
Tragl, K. H. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6409-9_11
DIABETIC FOOT DISEASE IN KING GEORGE HOSPITAL, VISHAKAPATNAM: A DESCRIPTIVE STUDY ON 100 PATIENTS
Kishore Babu, A., Bhaghavan Naik, M., Madhulikia, M., et al. (2015) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2015/245
“Ischemia of the endoneurial microvascular circulation induced by metabolic abnormalities from hyperglycemia is believed to be the underlying mechanism for nerve deterioration.([8])”
BackgroundResearch paper Characterization of hearing loss in aged type II diabetics
Frisina, S. T., Mapes, F. M., Kim, S., et al. (2006)
Winata, J., Panda, A. L., & Azis, R. A. (2015) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v36i1.436
Hariprasad, M. G., Razdan, R., & Tc, Y. (2019) · Archives of Diabetes & Obesity · doi:10.32474/ctcsa.2019.02.000135
elsalam, S. A., Ragab, M., Kandeil, M. A., et al. (2007) · Journal of Veterinary Medical Research · doi:10.21608/jvmr.2007.77895
“Furthermore, Schroeder et al., (2005) attributed the mechanism of action of LA to its blocking effect on interleukin- 1beta that is secreted by activated macrophages in response to immune- mediated process causing islet cell death in IDDM.”
BackgroundDudele, A., Rasmussen, P. M., & Østergaard, L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579373
“, diabetic peripheral neuropathy (DPN) and neuropathic pain conditions (Cameron and Cotter, 1997; Lim et al., 2015).”
Background
Metadata
- Authors
- Cameron, N. E., & Cotter, M. A.
- Affiliations
- University of Aberdeen (GB)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-09-01
- Volume
- 46
- Issue
- Supplement_2
- Pages
- S31-S37
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2151689386
- Cited by
- 312
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 11 · 2019: 9 · 2018: 7 · 2017: 9 · 2016: 7 · 2015: 12 · 2014: 12 · 2013: 10 · 2012: 8
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- diabetic neuropathy, nerve blood flow, nerve conduction velocity, polyol pathway, advanced glycation end products, oxidative stress, aldose reductase inhibitors, sorbitol, glutathione, vasa nervorum, angiotensin receptor blockers, nerve regeneration, aminoguanidine, evening primrose oil, gamma-linolenic acid, nitric oxide, vasodilation, free radicals, endothelial injury
- MeSH terms
- Animals, Carnitine, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Endothelium, Vascular, Fatty Acids, Essential, Glycosylation, Humans, Nerve Tissue, Oxidation-Reduction, Regional Blood Flow, Sugar Alcohols, Vasodilator Agents, Reactive Oxygen Species, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review